The Journal of Heart and Lung Transplantation

publication venue for

Estimating Prognosis Among Advanced Heart Failure Patients Referred for Advanced Heart Failure Therapies at the University Health Network 2024
Predictive Models Refine Physician Prognostication: A Secondary Analysis Evaluating Integrated Model and Physician Prognostic Estimates in Heart Failure Patients with Reduced Left Ventricular Ejection Fraction 2024
Use of Induction Therapy Post Heart Transplantation - Clinical Practice Recommendations Based on Systematic Review and Network Meta-Analysis of Evidence 2023
Outcomes of Children with Hypoplastic Left Heart Syndrome and Systemic Ventricular Dysfunction on Guideline Directed Medical Therapy 2022
Predicting 1-Year Mortality in Ambulatory Heart Failure Patients: Empiric Models Outperform Physician Intuitive Estimates 2022
Use of Induction Therapy Post Heart Transplantation: A Heart Transplant Rapid Recommendations 2022
Left Ventricular Dilatation Impacts Heart Transplant and Death in Left Ventricular Non-Compaction Cardiomyopathy 2021
Sustained Ventricular Fibrillation in a Conscious Pediatric LVAD Patient 2021
Ex Vivo Lung Perfusion Resuscitated Donor Lungs and Subsequent Acute Rejection and Airway Complications: A Systematic Review and Meta-Analysis 2020
Extracorporeal Membrane Oxygenation for Early Graft Dysfunction Following Heart Transplantation: A Systematic Review and Meta-Analysis 2020
Incidence and Impact of Primary Graft Dysfunction in Adult Heart Transplant Recipients: A Systematic Review and Meta-Analysis 2020
Mortality in Patients with Cardiogenic Shock Supported with Veno-Arterial Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis Evaluating the Impact of Etiology 2020
Patients with Fulminant Myocarditis Supported with Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis of Short-Term Mortality and Impact of Risk Factors 2020
Single Centre Outcomes of Heart Re-Transplantation: A Matter of Indication? 2020
Application of Predicted Heart Mass Difference in a Canadian Cohort of Heart Transplant Recipients 2019
Correlation of Initial Echocardiographic Parameters and Emergency Room Admission Rates in Heart Failure Clinic Patients 2019
Directly to a DOAC? Safety of Alternatives to Warfarin for Anticoagulation in Heart Transplantation 2019
Does Left Atrial Appendage Occlusion in LVAD Patients Impact Outcomes: A Single Centre Study 2019
Heart Transplant Induction Therapy in Canada: A National Survey 2019
Initial Experience with Non-Perfused Organ Donors for Lung Transplantation 2019
Physician Prediction versus Model Predicted Prognosis in Ambulatory Patients with Heart Failure 2019
Predictors of Mortality Post Lung Transplantation: Systematic Review and Meta-Analysis 2019
Right Ventricular Failure Risk Prediction Models in Patients Undergoing Left Ventricular Assist Device Implantation: A Systematic Review 2019
The Impact of Frailty on Survival in Patients Undergoing Advanced Therapies for Heart Failure 2019
Assessing the Predictive Validity of ISHLT's Primary Graft Dysfunction Classification Instrument 2018
Association Between Common Measures of Graft Function and Mortality Post Heart Transplant (HT) 2018
Donor Specific Antibodies in Heart Transplantation: Do Clinicians Need to do Something Always? 2018
Peak Oxygen Consumption as a Prognostic Marker in Patients with Cardiac Amyloidosis 2017
The Microbiome of the Respiratory Tract After Heart Transplantation 2017
Time Dependent Covariate Method for Assessing Impact of CAV Severity on Mortality After Cardiac Transplantation 2017
Impact of Health Literacy on Knowledge and Self-Care in Heart Failure Patients, Pre- and Post-Intervention 2016
Frailty Phenotype Is Associated With Survival as Predicted By the Seattle Heart Failure Model in Heart Failure Patients Referred for Advanced Therapies 2015
Is Pannus an Innocent Bystander in Mechanical Circulatory Support Thrombosis? Examining the Pathology of 50 Explanted Devices 2015
Outcomes in Adult Congenital Heart Failure Patients Undergoing Heart Transplantation: A Systematic Review and Meta-Analysis 2015
Predicting Survival in Heart Failure Patients With an Implantable Cardioverter Defibrillator: The Heart Failure Meta-Score 2014
Proliferation Signal Inhibitors for Cardiac Allograft Vasculopathy in Heart Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 2014
Changes in Circulating Progenitor Cells Are Associated with Functional Capacity in Heart Failure Patients: A Longitudinal Study 2013
Contemporary Outcomes of Lung Transplantation Using Extracorporeal Membrane Oxygenation as Bridge 2013
Cost-Effectiveness of Ventricular Assist Device Therapy as a Bridge to Transplant in Comparison to Non-Bridged Cardiac Recipients 2013
Risk Prediction Models for Mortality in Ambulatory Heart Failure Patients: A Systematic Review 2013
128 Redo Sternotomy in Patients Undergoing Heart Transplantation: A Propensity-Matched Survival Analysis of the United Network for Organ Sharing Database 2012
165 Analysis of over 1000 Patients Listed for Combined Heart-Kidney Transplant in the Modern Era 2012
458 Endothelial Progenitor Cells Independently Predict Functional Capacity in Heart Failure Patients 2012
49 Five Years of Lung Transplantation Since the Implementation of the Lung Allocation Score: A Comparative Analysis of Patient Characteristics and Outcomes 2012
160 Assessment of Quality of Care in Lung Transplant Patients 2011
455 Is Reduced Pump Speed Associated with Less Gastrointestinal Bleeding among Patients on Non-Pulsatile Left Ventricular Assist Devices? 2011
483: Demonstration of Improvement in Health-Related Quality of Life Post Lung Transplantation: Results Based on the Health Utilities Index (HUI) 2008
199: Endothelin-1 antagonism prevents CyA induced vasomotor impairment: Implication for transplant related vascular injury 2007
Endothelin-1 exacerbates hypoxic injury through eNOS derived free radical production: Implication for primary allograft dysfunction 2007
365 2006
367 2006
A prospective randomized controlled trial of initial immunosuppression with ALG versus OKT3 in recipients of cardiac allografts. 1992
A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF INITIAL IMMUNOSUPPRESSION WITH ALG VERSUS OKT3 IN RECIPIENTS OF CARDIAC ALLOGRAFTS
REDO LUNG TRANSPLANTATION - A NORTH-AMERICAN EUROPEAN EXPERIENCE
Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial.. S1053-2498(25)01979-5. 2025
Knowledge gaps in heart and lung donation after the circulatory determination of death: Report of a workshop of the National Heart, Lung, and Blood Institute. 43:1021-1029. 2024
Cardiac allograft vasculopathy and survival in pediatric heart transplant recipients transitioned to adult care. 43:229-237. 2024
Reproductive health after thoracic transplantation: An ISHLT expert consensus statement. 42:e1-e42. 2023
Relationships between 2018 UNOS heart policy and transplant outcomes in metropolitan, micropolitan, and rural settings. 41:1228-1236. 2022
Predictors of 1-year mortality after adult lung transplantation: Systematic review and meta-analyses. 41:937-951. 2022
Risk factors of invasive fungal infections in lung transplant recipients: A systematic review and meta-analysis. 41:255-262. 2022
Successful lung transplantation from lungs procured 12 hours after withdrawal of life-sustaining therapy: Changing the paradigm of controlled DCD donors?. 40:1020-1021. 2021
Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis. 40:642-651. 2021
Mortality in patients with cardiogenic shock supported with VA ECMO: A systematic review and meta-analysis evaluating the impact of etiology on 29,289 patients. 40:260-268. 2021
Pregnancy after heart transplantation: A second-generation transmission of the gift of life—in reply. 40:235-235. 2021
Letter to the editor: Increased sensitivity to ischemic interval of donor hearts with diminished left ventricular function.. 39:1323. 2020
Ex Vivo Lung Perfusion Resuscitated Donor Lungs and Subsequent Acute Rejection and Airway Complications: A Systematic Review and Meta-Analysis. 39:S371-S371. 2020
Pregnancy outcomes in women with cardiothoracic transplants: A Systematic review and meta-analysis. 39:93-102. 2020
Infectious complications after heart transplantation in patients screened with gene expression profiling. 38:611-618. 2019
Outcomes in Pediatric Hypertrophic Cardiomyopathy Patients with Reduced Systolic Ventricular Function. 38:S467-S467. 2019
Pediatric Hypertrophic Cardiomyopathy: Survival and Prognostic Indicators in the Current Era. 38:S465-S465. 2019
Validation of the International Society for Heart and Lung Transplantation primary graft dysfunction instrument in heart transplantation. 38:260-266. 2019
Risk evaluation using gene expression screening to monitor for acute cellular rejection in heart transplant recipients. 38:51-58. 2019
IVC Assessment by Ultrasound in Acute and Ambulatory Heart Failure Patients Predictive of Mortality and Readmissions: A Systematic Review. 37:S323-S323. 2018
Left Atrial Function During the First Year After Pediatric Heart Transplantation. 36:S104-S105. 2017
The Microbiome of the Respiratory Tract After Heart Transplantation. 36:S50-S50. 2017
Outcomes in adult congenital heart disease patients undergoing heart transplantation: A systematic review and meta-analysis. 35:1337-1347. 2016
Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes. 34:685-692. 2015
394 Control of Cardiac Metabolism and Growth by DJ-1. 31:S140-S140. 2012
Tacrolimus preserves vasomotor function and maintains vascular homeostasis. 30:583-588. 2011
Endothelin-1 antagonism and nitric oxide augmentation prevents cyclosporine-induced vasomotor impairment. 30:77-85. 2011
Exercise training after lung transplantation: A systematic review. 29:497-503. 2010
Activated Protein C in Ischemia-Reperfusion Injury After Experimental Lung Transplantation. 28:1180-1184. 2009
Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. 26:350-356. 2007
Scedosporium apiospermum (Pseudoallescheria boydii) Infection in Lung Transplant Recipients. 26:350-356. 2007
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part VI: Treatment. 24:1489-1500. 2005
Angiographic, Pathologic, and Clinical Relationships in Coronary Artery Disease in Cardiac Allografts. 24:1218-1225. 2005
Bilateral lung transplantation for metastatic leiomyosarcoma. 23:912-915. 2004
Improvement of apparently fixed pulmonary hypertension with cardiac resynchronization therapy. 23:650-652. 2004
Bile acids in bronchoalveolar lavage after lung transplantation as a marker of pulmonary aspiration associated with alveolar neutrophilia. 23:s42. 2004
Early experience with sirolimus based, calcineurin inhibitor free, immunosuppression for lung transplant recipients. 23:s69. 2004
Long term outcome after single and bilateral lung transplantation for end-stage pulmonary hypertension. 23:s94. 2004
Impact of bronchogenic carcinoma in patients undergoing lung transplantation. results of an international survey. 22:s161. 2003
Lung transplantation with donors 60 years of age and older. 22:s87. 2003
Nitric oxide synthase gene expression, enzyme levels and activity are not inhibited by inhaled nitric oxide in human lung transplant reperfusion injury. 21:170. 2002
The role of donor age and ischemic time on survival following orthotopic heart transplantation. 18:310-319. 1999
Basis for aerobic impairment in patients after heart transplantation.. 14:1073-1080. 1995
Redo lung transplantation: a North American-European experience.. 12:5-15. 1993
New trends in lung preservation: a collective review.. 11:377-392. 1992
Extending cardiac allograft ischemic time and donor age: effect on survival and long-term cardiac function.. 10:394-400. 1991
Reduced incidence of severe infection after heart transplantation with low-intensity immunosuppression.. 10:894-900. 1991
Successful use of the "unacceptable" heart donor.. 10:28-32. 1991
Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologic status?. 9:699-706. 1990
Special considerations for heart transplantation in congenital heart disease. The Paediatric Heart Transplant Group.. 9:602-607. 1990
Benefits of avoidance of induction immunosuppression in heart transplantation.. 8:311-314. 1989
De novo coronary artery grafting in a heart transplant recipient.. 7:468-470. 1988
Effect of betablockade on dynamic exercise in human heart transplant recipients.. 4:312-314. 1985
Basis for aerobic impairment in patients after heart transplantation. 14:1073-1080.
HLA MISMATCHING AND OUTCOME IN HEART, HEART-LUNG, AND SINGLE-LUNG TRANSPLANTATION. 14:444-451.
NEW TRENDS IN LUNG PRESERVATION - A COLLECTIVE REVIEW. 11:377-392.
OUTCOME IN PAIRED RECIPIENTS OF SINGLE-LUNG TRANSPLANTS FROM THE SAME DONOR. 14:878-882.
SUCCESSFUL USE OF THE UNACCEPTABLE HEART-DONOR. 10:28-32.

The Journal of Heart and Lung Transplantation Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)